Only ~14% Of U.S. Adults Have Gotten Latest Covid-19 Vaccine Update
![[Post New]](/jforum/templates/default/images/icon_minipost_new.gif){kind=icon}
Anonymous
1) Long covid. Omicron is far less likely to lead to long covid than earlier, more virulent strains. Also, many respiratory illnesses can have lingering symptoms which is why long covid studies need to have a control. This study found that while 40% of recovered covid patients ended up with symptoms associated with long covid, 54% of patients who recovered from a non-covid respiratory illness also ended up with the same longer-term symptoms. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799116 2) The Nature (VA health records) article is a study of old, sick men and does not have broader relevance. Participants in the study were: 87% male, average age 60, majority smokers, 18% were admitted to the hospital for their first infection, 36% had diabetes, 24% had cardiovascular disease & 7% lived in nursing homes. Do old, sick men have worse outcomes with multiple illnesses/hospitalizations? Yes. Does this have implications for the broader population? No. |
Anonymous
Why not? Aren't you scared you'll get covid????? |
Anonymous
You do realize Cornell's population is near to the lowest risk? (College aged) |
Anonymous
Yes, agreed. Young people face almost no serious risk from Omicron yet face the greatest risk from vaccine side effects. Which is why it is surprising that 70 colleges (not Cornell) still mandate the vaccine for their students and some, like Wellesley, mandate for students but not for staff even though staff are older and more vulnerable. https://www.wellesley.edu/coronavirus The colleges with remaining vaccine mandates stress the need to protect their community; while students face little health risk from covid, they live in close quarters so transmission risks are high. Which is what makes Cornell's statement so noteworthy. Cornell believes that vaccine mandates will not make much of a difference on transmission even for individuals living in close quarters. |
Anonymous
Does Harvard mandate vaccination? |
Anonymous
NP. No. Not the least bit scared Aside from the fact the the vaccine won’t prevent you from getting it I’m not at all worried about getting it. |
Anonymous
| Don’t forget that people get Covid anyway even if they get the vaccine. This is why people stopped getting the vaccine . |
Anonymous
But it reportedly prevents severity and or minimize the severity, and likely sometimes does prevent it all together. I think it may have been said, it can also prevent asymptomatic carrying. |
Anonymous
+1 Still going to get it and spread it so why bother? |
Anonymous
To slow the spread. Minimize the symptoms. Protect others. |
Anonymous
And unfortunately overselling the covid vaccine's effectiveness has now led people to decline the flu shot as well. |
Anonymous
This is from Johns Hopkins a widely trusted and respected source. "Studies show that the <new> updated 2023 -2024 vaccine is effective against the variants currently causing the majority of COVID-19 cases in the U.S." "How is the 2023–2024 COVID-19 vaccine different from previous COVID-19 vaccines? The 2023–2024 COVID-19 vaccine targets XBB.1.5, a subvariant of Omicron. While none of the variants currently circulating are exact matches to the vaccine, they are all closely related to the XBB.1.5 strain. Studies show that the updated vaccine is effective against the variants currently causing the majority of COVID-19 cases in the U.S." https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/covid-19-vaccine-what-you-need-to-know#:~:text=The%202023–2024%20COVID%2D19%20vaccine%20targets%20XBB.1.5,to%20the%20XBB.1.5%20strain. |
Anonymous
| It seems like the vax stopped the hospital and morgue overcrowding in 2020-21. Remember when ICUs were triaging people because they ran out of beds? I think most people have antibodies from prior infections and injections protecting them somewhat now, so it doesn't seem like as big of a deal. |
Anonymous
Omicron is milder than the earlier strains. If you look at Society for Actuaries data, excess mortality from covid remained high all through 2021 despite the covid vaccines. It wasn't until early 2022 that excess mortality from covid fell plunged, which occurred as Omicron became the dominant strain. https://www.soa.org/4ac0fd/globalassets/assets/files/resources/experience-studies/2023/group-life-covid-mort-06-23.pdf Page 27, Table 5.9 Omicron affects the upper respiratory system more than earlier strains, yielding far milder outcomes. All of today's circulating covid strains are Omicron variants. https://covariants.org/ |
Anonymous
Look at the CDC UptoDate page. It says the reason to take the 2023-24 updated vaccine is to reduce the severity of illness. It does not mention slowing the spread/transmission. The lack of mention of that latter factor is notable. "CDC recommends the 2023–2024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna, or Novavax, to protect against serious illness from COVID-19." https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html Some people will also argue that vaccines reduce the likelihood of long covid. However, here's what the CDC website says on that: "Estimating vaccine effectiveness against post-acute conditions associated with COVID-19, including multisystem inflammatory syndrome (MIS) and Post-COVID Conditions (PCC), also known as Long COVID, is challenging because these outcomes are less common than severe acute disease. ... The broad spectrum of PCCs, including its various manifestations and lack of standard case definitions across surveillance platforms, makes it challenging to evaluate vaccine effectiveness against these outcomes and interpret findings across studies." https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/how-they-work.html Thus, reducing the severity of illness is the only reason cited on the CDC's UptoDate page to justify its broad-based recommendations for the new booster. However, Omicron is milder than earlier strains and covid hospitalizations and deaths are near record lows. Non-elderly, non-vulnerable people face very little risk of severe outcomes from Omicron. Which is why nearly every other nation in the world only recommends the current booster for the vulnerable and elderly. |